The 20 Best Immune Thrombocytopenic Purpura (ITP) Doctors Near Me in Columbia, MD

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant. Dr. Narang is board certified in American Board Of Internal Medicine.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain. Dr. Lee is board certified in American Board Of Internal Medicine.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Sastry is board certified in American Board Of Internal Medicine.

Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider practicing medicine in Columbia, Maryland. Dr. Nimmagadda is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma. Dr. Nimmagadda is board certified in American Board Of Internal Medicine.

Ari Elman is an Oncologist practicing medicine in Columbia, Maryland. He has been practicing medicine for over 17 years. Dr. Elman is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Multiple Myeloma.

Mateen Awan is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Awan is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Nephrosclerosis, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Gastrostomy, and Endoscopy.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, and Congenital Hemolytic Anemia. Dr. Naik is board certified in American Board Of Internal Medicine.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine.

Dr. Resar's studies molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Her research focuses on the HMG-I/Y gene family, which is widely overexpressed and functions as oncogenes in human cancers. Her laboratory recently developed transgenic mice overexpressing HMG-I; all mice develop aggressive lymphoid malignancy similar to leukemia and lymphoma in humans. Her studies also demonstrate that this gene is overexpressed in human lymphoid and other malignancies. Translational studies are underway to determine if overexpression of HMG-I is a marker for more aggressive human cancers. Resar's long-term goal is to develop more rational therapies that interfere with HMG-I/Y function in neoplastic transformation. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her clinical expertise encompasses Anemia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP). Dr. Resar is board certified in American Board Of Pediatrics.

Dr. Matthew Merguerian is a pediatric hematologist specializing in bleeding and clotting disorders. His research is focused on bleeding disorders resulting from platelet dysfunction. His lab is interested in understanding the mechanisms behind platelet dysfunction and in developing platelet-targeted therapies that could alleviate abnormal bleeding or clotting. Dr. Merguerian is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His clinical expertise encompasses Blood Clots, Leukemia, and Immune Thrombocytopenic Purpura (ITP). Dr. Merguerian is board certified in American Board Of Pediatrics.

Dr. Friedman is the King Fahd Professor of Oncology and Professor of Pediatrics at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. He received his M.D. from the Harvard Medical School (1983), did his pediatric internship and residency at Boston Children's Hospital (1983-86), and completed a fellowship in pediatric hematology-oncology at Johns Hopkins (1986-89). As a fellow, he did post-doctoral research at the Carnegie Institution Department of Embryology located on the Johns Hopkins Homewood campus. Dr. Friedman has served on the Pediatric Oncology faculty at Johns Hopkins since 1989. His laboratory focuses on investigation of normal and abnormal blood-cell formation. Dr. Friedman also cares for children with cancer, specializing in the treatment of leukemia. Dr. Friedman is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His clinical expertise encompasses Leukemia, Glioma, Acute Lymphoblastic Leukemia (ALL), and Neuroblastoma. Dr. Friedman is board certified in American Board Of Pediatrics.

Dr. Stacy Cooper is the Director of the Pediatric Hematologic Malignancy Program, Director of the Pediatric Hematology/Oncology Fellowship Program, and Clinical Director of the Pediatric Oncology Inpatient Program at the Johns Hopkins School of Medicine. Dr. Cooper received her undergraduate degree in Biology and Spanish at the University of Notre Dame. She earned her M.D. at SUNY Upstate Medical University. She completed her general pediatric residency and chief residency at the Johns Hopkins School of Medicine. She completed her pediatric hematology-oncology fellowship with the Johns Hopkins-National Institutes of Health. Dr. Cooper joined the Johns Hopkins faculty in 2015. Her research focuses on clinical research in acute lymphoblastic leukemia, as well as medical education scholarship related to fellowship training. Dr. Cooper is a member of the American Board of Pediatrics, the American Society of Hematology, the American Society of Pediatric Hematology Oncology and the Association of Pediatric Program Directors. Dr. Cooper is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Leukemia. Dr. Cooper is board certified in American Board Of Pediatrics.

Emily Rao is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Rao is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her clinical expertise encompasses Sickle Cell Disease, Von Willebrand Disease (VWD), and Immune Thrombocytopenic Purpura (ITP). Dr. Rao is board certified in American Board Of Pediatrics.

Robyn Gartrell, MD, MS is a physician-scientist and pediatric oncologist who joined the faculty at Johns Hopkins University School of Medicine as Assistant Professor in January 2024. Dr. Gartrell completed her clinical pediatric hematology/oncology fellowship at New York Presbyterian / Columbia University Irving Medical Center (CUIMC), and a postdoctoral fellowship in Immunotherapy and Precision Medicine. She also completed a Master of Science in Patient Oriented Research as well as her first 5 years as faculty at CUIMC. Dr. Gartrell’s primary research focuses on combination approaches including radiation, chemotherapy, and other target agents with immunotherapy to improve response, increase survival, and decrease toxicity for children, adolescents, and young adults with cancer. Her laboratory uses advances in tumor immunology to develop more effective and more personalized therapies using multiplex platforms and immunogenomics to evaluate the tumor microenvironment and determine which pediatric tumor types, and which patients, will respond to immunotherapy. Dr. Gartrell is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, HER2 Negative Breast Cancer, and Pancreatic Ductal Adenocarcinoma. Dr. Gartrell is board certified in American Board Of Pediatrics.

Yang Ding is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Baltimore, Maryland. Dr. Ding is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Leukemia, and Langerhans Cell Histiocytosis. Dr. Ding is board certified in American Board Of Pediatrics.

Recognized as a dedicated and compassionate pediatric hematologist-oncologist, Dr. Keates-Baleeiro cares for patients in the Division of Pediatric Hematology at Johns Hopkins Children’s Center in Baltimore, Maryland. A pediatric hematologist-oncologist is a physician who has special training and experience in diagnosing and treating blood disorders and cancers in children, teens, and young adults. Dr. Keates-Baleeiro’s current clinical interests include pediatric cytopenias, coagulation disorders, platelet disorders, sickle-cell anemia, and hemophilia. Her research interests include rare bleeding disorders, porphyria, and neutropenia in children. Dr. Keates-Baleeiro received her medical degree from the Drexel University College of Medicine in 1999 and completed her internship at Cohen Children’s Medical Center and her pediatric residency at Children’s Hospital of Michigan in Detroit in 2002. She then went on to complete a fellowship in pediatric hematology-oncology at the University of Michigan’s C.S. Mott Children’s Hospital and Vanderbilt University Medical Center in 2003 and 2006, respectively. Passionate about teaching, Dr. Keates-Baleeiro also serves as an Assistant Professor of Pediatrics at the Johns Hopkins School of Medicine educating medical students, pediatric residents, and pediatric hematology oncology fellows. Dr. Keates is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Phosphoglycerate Kinase Deficiency, Sickle Cell Disease, Hemoglobin SC Disease, and Infantile Neutropenia. Dr. Keates is board certified in American Board Of Pediatrics.

Yiouli Ktena is a Pediatrics provider practicing medicine in Baltimore, Maryland. Dr. Ktena is rated as undefined provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Sickle Cell Disease, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant. Dr. Ktena is board certified in American Board Of Pediatrics.